Brain Cancer

Cerebral Glioblastoma

Female, 42 years

Patient Internal 103598333

ICD-10 code

C71.8 Malignant Neoplasm of Overlapping Sites of Brain

Diagnosis (Incl. Metastases/Stage) and Year

February 2021
Glioblastoma (WHO grade IV), IDH(-), TERT(-), MGMT(+), Chromosome 7 Trisomy and Chromosome 10 Monosomy, BRAF(-).

Previous Treatment

Radiation Therapy, Chemotherapy (Temozolomide + Lomustine).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~ 14 months from diagnosis.

Treatment Provided

Autologous DCV (5 doses) and CIK (4doses) over a period of 3 months.

Patient Survival/Condition and Year
Date of Review: 15/10/2023

The patient has survived 18 months from the diagnosis. It can be concluded that Immunotherapy, alongside Radiation Therapy and Chemotherapy, has extended the patient’s survival by 4 months over the median survival.